TYLENOL W Drug Patent Profile

When do Tylenol W patents expire, and when can generic versions of Tylenol W launch?

Tylenol W is a drug marketed by Ortho Mcneil Pharm and Janssen Pharms and is included in five NDAs.

The generic ingredient in TYLENOL W is acetaminophen; codeine phosphate. There are sixty-six drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Tylenol W

A generic version of TYLENOL W was approved as acetaminophen; codeine phosphate by SUN PHARM INDS LTD on December 31^st, 1969.

Summary for TYLENOL W

US Patents:	0
Applicants:	2
NDAs:	5

US Patents and Regulatory Information for TYLENOL W

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ortho Mcneil Pharm	TYLENOL W/ CODEINE	acetaminophen; codeine phosphate	SOLUTION;ORAL	085057-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No
Janssen Pharms	TYLENOL W/ CODEINE NO. 2	acetaminophen; codeine phosphate	TABLET;ORAL	085055-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No
Ortho Mcneil Pharm	TYLENOL W/ CODEINE	acetaminophen; codeine phosphate	TABLET;ORAL	085056-003	Approved Prior to Jan 1, 1982		DISCN	No	No
Ortho Mcneil Pharm	TYLENOL W/ CODEINE NO. 3	acetaminophen; codeine phosphate	CAPSULE;ORAL	087422-001	Approved Prior to Jan 1, 1982		DISCN	No	No